DeepCure, a company specializing in AI-driven therapeutic discovery, has introduced a development in chemical synthesis with its Inspired Chemistry™ platform. …

Owkin, a pioneering TechBio company leveraging advanced causal* AI for precision drug discovery, has announced a significant expansion of its …

Tempus AI has officially filed its S-1 registration statement with the Securities and Exchange Commission (SEC), marking a significant step …

Sanofi, Formation Bio, and OpenAI have announced a pioneering collaboration aimed at accelerating drug development using artificial intelligence (AI). This …

LabGenius, a leading drug discovery company leveraging machine learning (ML) to discover novel therapeutic antibodies, has successfully completed a £35 …

Insilico Medicine, a clinical-stage AI-driven drug discovery company, in collaboration with NVIDIA, has introduced nach0, a novel large language model …

AstraZeneca has announced plans to construct a $1.5 billion manufacturing facility in Singapore dedicated to producing antibody-drug conjugates (ADCs), a …

Accenture has strategically invested in Turbine, a company specializing in predictive simulation with a platform aimed at interpreting human biology. …

Insilico Medicine, a biotechnology company specializing in generative artificial intelligence, has begun dosing patients in the first clinical trial for …

Veranova and Phorum.AI have partnered to revolutionize pharmaceutical manufacturing processes using generative artificial intelligence. This collaboration combines Veranova's extensive 20-year …

Karius Inc., a leading company in genomic diagnostics for infectious diseases, announced that its Karius Test has received the FDA's …